Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Astrazeneca's Trial, Schott Pharma Up, Rheinmetall Sinks | Stock Movers
Posted
July 9, 2026
Views
183
Likes
2
Engagement
1.09%
July 9, 2026
183
2
1.09%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
4:27Now PlayingToday's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- AstraZeneca and Ionis Pharmaceuticals Inc.’s gene silencer drug Wainua failed to help prevent heart problems in patients with a rare and potentially fatal disease of the organ. AstraZeneca’s shares slumped.
- Schott Pharma shares jump by a record 22% after the company improved its guidance for the full year, prompting an upgrade at RBC Capital Markets. The stock is trading at its highest level since October.
- Bulgaria’s government may not be able to secure funding for joint project with Rheinmetall for NATO-standard shell, gunpowder plant, Mediapool news website reports, citing Economy Minister Alexander Pulev.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Astrazeneca's Trial, Schott Pharma Up, Rheinmetall Sinks
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
